-
What to look out for in the Premier League transfer window
-
Maduro elusive on US attack, open to dialogue
-
Venus Williams gets Australian Open wildcard aged 45
-
Trump blames bruised hand on aspirin, denies falling asleep
-
Dress for success: Mexican president's ideological attire
-
Best of frenemies: Saudi, UAE rivalry bursts into view
-
'Positive signs' on hospitalised Australian cricket great Martyn
-
North Korean leader's daughter in first visit to symbolic mausoleum
-
The Crans-Montana fire: a Swiss tragedy that raises questions
-
Around 40 killed as fire ravages Swiss ski resort New Year party
-
Australia's Khawaja to retire after Ashes finale, slams 'racial stereotyping'
-
Frank accepts 'boring' jibes from Spurs fans after Brentford stalemate
-
Guardiola vexed by Man City's sloppy finishing in Sunderland draw
-
Tears and stunned silence at vigil for Swiss fire victims
-
Wembanyama to miss Spurs' NBA game Friday at Indiana: reports
-
Man City charge stalls at Sunderland, Liverpool held by Leeds
-
Man City's title bid dented by Sunderland stalemate
-
Australia's Khawaja announces retirement from international cricket
-
Niners seek win for home-field playoff edge into Super Bowl
-
New York mayor Mamdani pledges left-wing success after taking office
-
Slot frustrated by blunt Liverpool in Leeds stalemate
-
Toothless Liverpool held by Leeds
-
Dozens killed as fire ravages Swiss ski resort New Year party
-
K-pop stars BTS to release album in March ahead of world tour
-
Fresh clashes kill six in Iran cost-of-living protests
-
Nigeria kicks off new tax regime vowing relief for low earners
-
Dozens killed in fire at Swiss ski resort New Year party
-
Leftist Mamdani begins first day as New York mayor
-
Dozens believed killed in fire at Swiss ski resort New Year party
-
Brazil Supreme Court rejects Bolsonaro request for house arrest on health concerns
-
Israel confirms ban on 37 NGOs in Gaza
-
Russia blames Ukraine for deadly New Year drone strike
-
Coach Maresca leaves Chelsea - club
-
'Several dozen' believed killed in fire at Swiss ski resort New Year party
-
China's BYD logs record EV sales in 2025
-
Yemen separatists say Saudi-backed forces to deploy in seized territories
-
Wales rugby star Rees-Zammit signs long-term deal to stay at Bristol
-
'Several dozen' believed killed in fire at Swiss ski resort New Year bash
-
Hakimi, Salah and Osimhen head star-packed AFCON last-16 cast
-
Israel says it 'will enforce' ban on 37 NGOs in Gaza
-
Near record number of small boat migrants reach UK in 2025
-
Several dead as fire ravages bar in Swiss ski resort town Crans Montana: police
-
Tsitsipas considered quitting tennis during injury-hit 2025
-
Sabalenka wants 'Battle of the Sexes' rematch and revenge
-
Osaka drawing inspiration from family at United Cup
-
Leftist Mamdani takes over as New York mayor under Trump shadow
-
Israel's Netanyahu among partygoers at Trump's New Year's Eve fete
-
Champagnie, Wemby lead Spurs comeback in Knicks thriller
-
Eight dead in US strikes on alleged drug boats: US military
-
Trump joins criticism of Clooney's French passport
| SCS | 0.12% | 16.14 | $ | |
| CMSC | -0.15% | 22.65 | $ | |
| RIO | -0.61% | 80.03 | $ | |
| NGG | -0.54% | 77.35 | $ | |
| GSK | -0.53% | 49.04 | $ | |
| AZN | -0.63% | 91.93 | $ | |
| BCC | -0.26% | 73.6 | $ | |
| JRI | 0.22% | 13.61 | $ | |
| CMSD | 0.09% | 23.15 | $ | |
| BCE | 1.05% | 23.82 | $ | |
| RYCEF | 0.13% | 15.51 | $ | |
| BTI | 0.12% | 56.62 | $ | |
| RBGPF | -0.37% | 80.75 | $ | |
| RELX | -1.71% | 40.42 | $ | |
| VOD | -0.15% | 13.21 | $ | |
| BP | -0.06% | 34.73 | $ |
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment
Watch the "What This Means" video here
IRVINE, CA / ACCESS Newswire / September 26, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor "What This Means" segment.
As part of the segment, Mr. Berman discussed the Company's recent news announcing it filed a request for supervisory appeal of the not-approvable letter from the Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) received on August 19, 2025, in response to its Premarket Approval (PMA) application for the VenoValve®, a surgical replacement venous valve for treating severe deep chronic venous insufficiency (CVI).
The Virtual Investor "What This Means" segment featuring enVVeno Medical is now available here.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of severe deep Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The Company is currently performing the final testing necessary to seek IDE approval from the FDA to begin the U.S. pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
Y.Nakamura--AMWN